We further tested whether the inhibition of NF-κB was due to an interaction between the sulfhydryl group of the p50 subunit of NF-κB and thiacremonone, as previously seen in colon cancer cells [15]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.